chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a registered nurse referring to a 53 year old patient (gender not reported) who was vaccinated with RECOMBIVAX HB (lot # not reported) on 24-JAN-2007, 01-FEB-2007 and 15-FEB-2007. No adverse symptoms reported. Additional information has been requested.
2/24/21 Injection Site arm soreness  (8 hours) 2/25/21 - Right arm pain, nausea, body aches  (12 hours) stomach pain (6 hours) Migraine-like headache (8 hours) 2/26/21 Tired 8 hours
Tired, fever, chills, and headaches. Not sure if this is result of shot. Transient Global Amnesia. Feb 21.
TEETH SENSITIVITY; SHAKING STATING I THOUGHT I WAS  GOING TO HAVE A CONVULSION; CHILLS SO BAD I FELT LIKE YOU WERE  IN A FREEZING RIVER; NAUSEA; FATIGUE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802068, expiry: UNKNOWN) dose was not reported, administered on 23-MAR-2021 approximately at 09:30 in right arm for prophylactic vaccination. No concomitant medications were reported. On 23-MAR-2021 12:30, the subject experienced teeth sensitivity. On 23-MAR-2021 12:30, the subject experienced shaking stating i thought i was going to have a convulsion. On 23-MAR-2021 12:30, the subject experienced chills so bad i felt like you were in a freezing river. On 23-MAR-2021 12:30, the subject experienced nausea. On 23-MAR-2021 12:30, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from teeth sensitivity on 23-MAR-2021, and shaking stating i thought i was going to have a convulsion, chills so bad i felt like you were in a freezing river, nausea, and fatigue on 24-MAR-2021 03:00. This report was non-serious.
MMR given 08-01-2008. Parent reported "swollen neck" on 09-24-2008. Serum amylase
I tested positive for COVID-19 on 10/27/22, but my symptoms started 10/25/22. I had a cough, fever, and congestion. I was taking NYQUIL, DAYQUIL, and TYLENOL. I was prescribed 5 days' worth of PAXLOVID. I started feeling better after taking the second day of PAXLOVID. I had a rebound case a week later. I was having the same irritated symptom in my throat. I decided to test again and tested positive again.
PT CALLED PHARMACY AND STATED THAT SHE HAS BEEN FEELING FATIGUE, HEADACHE, DECREASED APPITITE.   I RECOMMENDED TO TAKE ACETAMINOPHEN TO HELP WITH THE SYMPTOMS, AND IF SYMPTOMS GET WORSE TO GET MEDICAL ATTENTION
On 3/7/09, pt developed intermittent fussiness and apparent abdominal pain (legs curling up).  Worsened over next 24 hours, then passed a bloody/mucousy (currant jelly) stool.  Referred to Er, where barium enema did NOT demostrate intussusception; however, symptoms resolved completely at that point and did not return.  Although study did not confirm intussusception, clinical course is very consistent w/ that process, and I suspect the intussusception resolved spontaneously prior to the study. 3/31/09-records received for DOS 3/8/09-presented to ED with C/O abdominal pain times 2 days, bloody stool this morning. Intermittent abdominal pain. DX: Hematochezia, abdominal pain.
Approximately 15 hours after getting vaccine, the morning after, noticed slight tongue discomfort. Feeling slight swelling of tongue,  noticed scalloped appearance. Noticed for about 24 hours, seems to be mostly normal now. Did not take any medication. Was not in any distress really, just seemed to be an uncommon side effect and thought I should report. Only medication allergy in past was keflex many years ago and was described as serum sickness and treated with Prednisone.
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium
Chills; Fever; soreness; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of PYREXIA (fever), VACCINATION SITE PAIN (soreness) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.  The patient's past medical history included No adverse event (No reported adverse event).  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced PYREXIA (fever), VACCINATION SITE PAIN (soreness) and CHILLS (chills). At the time of the report, PYREXIA (fever), VACCINATION SITE PAIN (soreness) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information was not provided.   Reporter did not allow further contact
Patient was given mixed dosing.  Had received Moderna 28 days prior and was scheduled for Moderna and unintentionally received Pfizer instead.
patient reports pain down to elbow and up through collar bone and all the way over to neck plus a very swollen knot at site of injection
Woke up at 4 am nauseous. I tried to go back to sleep. I was dizzy and throwing up by 6 am. I had very bad chills during the entire time. The throwing up and chills eased by around 10 am. I was tired all day and slept most of the day. I was still in bed and asleep for the night by 8 pm. I woke up the next day fine.
Very sore shoulder and fatigue for a few days.  Menstrual cycle changes - periods are much heavier and longer. Cramps changed from barely existent to barely tolerable pain. Cycle changed from 28 days to 26. More headaches, more mood changes, more brain fog both before and after period. This is all consistent with the changes to my period after my second Moderna covid shot back in early 2021.   Something new that I don?t remember from the other covid shots I?ve had, that a friend is reporting is also happening to her, is that my hair has been falling out at a moderately alarming rate since around 10/20/2022 - about a month after the shot.
Severe headache treated with ibuprofen and rest. Body aches, fatigue treated with rest and water. Low grade fever also treated with ibuprofen, rest and water.
Day prior to shot felt achy but not that sick. Day of shot felt ok. Day after shot pt woke up with sore throat that lasted a couple days, then on day 4 had head & chest congestion for "awhile". Pt went to urgent care for antibiotic on day 9. Symptoms slowly resolving even today.
Information has been received from a doctor of pharmacy concerning a 16 year old female patient with no relevant past drug history or concomitant medications who in December 2009, was vaccinated with the first dose of GARDASIL. There were no side effects after received the first dose. On 11-MAR-2010, the patient was vaccinated with the second dose of GARDASIL and also was vaccinated with a dose of unknown meningococcal vaccine (unspecified). It was reported that within one hour of getting her second dose of GARDASIL, on 11-MAR-2010, the patient experienced fever, lethargy, no energy and stomach cramping. The patient notified her physician of the events who advised her to monitor it for a few days. There were no lab tests performed. As a 14-MAR-2010, it was unknown if the patient would continue to receive the GARDASIL or meningococcal vaccine (unspecified). At the time of the report, the fever, no energy and stomach cramping persisted.
My menstrual period has changed. I am on Nexplanon birth control implant, I hardly bled before these vaccines doses, and now I am bleeding a lot, I actually bled through my pants. This is not normal and I would like it documented. Also, three weeks after my second dose, my left upper arm where I got both doses of this vaccine,  it is sore still. The soreness went after after a week and now it is back, this is also not normal. I also have a red rash that comes and goes in the same area. Both doses required me to take Benadryl afterwards because it causes my throat to itch.
This spontaneous report as received from a Certified Medical Assistant refers to unknown number of patients of unknown demographics. There was no information about the patients' concurrent conditions, concomitant therapies, drug reactions or allergies and medical history provided. On an unknown date, the patients were inadvertently administered RECOMBIVAX HB injection, lot #M023718, expiration date 09-AUG-2018 (formulation, strength, dose, route of administration were not reported) that had been improperly stored. No adverse effects were reported. The vaccine experienced a temperature excursion of 47 Fahrenheit degrees (F) for 5 minutes, which was detected by a digital data logger. There was no previous temperature excursion. This is one of several reports received from the same reporter. Additional information is not expected as the reporter did not wish to be contacted.; Sender's Comments: US-009507513-1701USA002060: US-009507513-1612USA012239: US-009507513-1701USA002059:
Information has been received from a physician concerning a 12 year old female who on 29-JUL-2008 was vaccinated with a dose of GARDASIL vaccine (yeast) 0.5 ml (route and administration site not reported). Other suspect therapy included varicella virus vaccine live (Oka/Merck) (MSD) (duration and dose not reported) and hepatitis A virus vaccine inactivated (manufacturer unknown). Other concomitant therapy included meningococcal ACYW conj vaccine (dip toxoid) (MENACTRA). After she received the dose of GARDASIL vaccine (yeast), she fainted. It was mentioned that the patient had not eaten most of the day. The patient sought medical attention in the office at time. Additional information has been requested.
Systemic: Fainting/Unresponsive-Medium, Systemic: Flushed/Sweating-Medium, Systemic: Hyperventilation-Medium.
Information has been received from a certified nurse assistant concerning a 68 year old male who was vaccinated with a dose of Varivax instead of a dose of Zostavax. There was no adverse event. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
Pt recvd 2nd HIBTITER on 17JUL91 & office viist week of 30SEP; pt had hypopigmentation @ the inject site & an area of identation of 3-4cm; mom noted reaction in JULY;
Joint Inflammation - Numbness and tightness in joints fingers, wrists, shoulders, neck, knees, feet.  Pain at 8/10 of threshold-decision point to seek hospital visitation.  Tightness back left and front right of heart /left chest cavity mostly from abnormal arythmia.  Onset ~6-12hrs post vaccination administration; episodic 6x / day with both decreasing severity and frequency.
This spontaneous report as received from a medical assistant refers to a 14 year old patient of unknown gender. The concurrent conditions, drug reactions/allergies and medical history of the patient were not reported. On 06-DEC-2016, the patient was vaccinated with a dose of improperly stored GARDASIL 9 with lot number M028323 and expiration date of 26-SEP-2018 (strength, dose, route of administration and anatomical location were unknown) for prophylaxis, which was stored at 1.1 Celsius degrees (C) for 27 minutes, 0.7 degrees C for 19 minutes, 1.1 degrees C for 36 minutes, 0.7 degrees C for 29 minutes, 1.3 degrees C for 17 minutes, 1.1 degrees C for 20 minutes, 0.9 degrees C for 26 minutes, 0.7 degrees C for 31 minutes and 1.2 degrees C for 24 minutes. There was no previous temperature excursion. Moreover, the temperature excursions were detected by a data logger. No concomitant therapies nor adverse effects were reported. No product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1701USA007921: US-009507513-1701USA007910: US-009507513-1701USA004148: US-009507513-1701USA003168: US-009507513-1701USA007912: US-009507513-1701USA007922: US-009507513-1701USA007881: US-009507513-1701USA007913: US-009507513-1701USA007882: US-009507513-1701USA004150: US-009507513-1701USA007958: US-009507513-1701USA007906: US-009507513-1701USA007895: US-009507513-1701USA007896: US-009507513-1701USA007923: US-009507513-1701USA004152: US-009507513-1701USA007883: US-009507513-1701USA007897: US-009507513-1701USA007884: US-009507513-1701USA007924: US-009507513-1701USA007925: US-009507513-1701USA007847: US-009507513-1701USA007885: US-009507513-1701USA007908: US-009507513-1701USA007909: US-009507513-1701USA007898: US-009507513-1701USA007914: US-009507513-1701USA007915: US-009507513-1701USA007916: US-009507513-1701USA007848: US-009507513-1701USA007849.
p/vax pt c/o being tired; quiet & c/o stomach ache; very warm outside; flushed face; felt better starting 8/29/99; mom stated she believes this problem could also be related to starting kindergarten all day
chills; aches; diarrhea; headache; nausea; vomiting; This is a spontaneous report from a non-contactable consumer (patient). This 22-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 12Apr2021 as single dose for COVID-19 immunization. Medical history was not provided. Prior to vaccination, the patient was not diagnosed with COVID-19. Patient was not pregnant, was not pregnant at the time of vaccination. Concomitant medications were not provided. Patient experienced chills, aches, diarrhea, headache, nausea, vomiting, all on 12Apr2021. This report was assessed as non-serious. Since the vaccination, the patient had not been tested for COVID-19. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Information has been received from a registered nurse concerning a approximate 49-month-old male who on 25-OCT-2006 was vaccinated with a dose of MMR (lot # 652328/0956R). On approximately 06-NOV-2007 ("within the last two weeks") the patient developed breakthrough chickenpox. At the time of the report the patient's status was unknown. A product quality complaint was not involved. This is one of several reports received from the same source. Additional information has been requested. 02/10/2010 Follow up information received from a nurse on 12-DEC-2007 indicated the patient developed chickenpox on 10-JUL-2007 and has since recovered. She reported they were havign a lot of cases of chickenpos in thier office, sometimes 1-2 casses a week. Most of the cases were following VARIVAX. She thought the patient was the only case following MMR. The nurse explained they have been reporting the cases via the rmp and also to the state. This is one of several reports received from the same source. Additional information has been requested.
Breakout of bumps all over face, neck, behind ears and on back. I had my injection at 1:00 pm EST waited my 15 minutes ran some errands then arrived home and noticed the breakout on my face at approximately 3:30 pm EST. Placed a call to my PCP, left a message for her to call me. The bumps continued to pop out I put hydrocortisone cream on them and took Benadryl .
Significantly different period: Normally I have a VERY light period lasting 4-5 days unaccompanied by pain.   For three  normal (for me) in length period cycles (30-32 days) after the 2nd vaccination I experienced the heaviest periods OF MY LIFE. Eight days of very  heavy flow, cramping with pain that was debilitating for a full three days during the heaviest part of the period. I did not seek medical attention but would have if my periods continued to be that heavy and painful. After three period cycles my periods slowly went back to my normal, as described above.
Received injection on January 7, 2021 and began itching on January 17. On January 18 she noticed the area was red and still had itching. On January 19 the area became warm, swollen and continued to be red.
Pt. received TDAP in (L) deltoid on 081610. On 081710 mother called c/o redness & swelling the size of a quarter - told to apply warm moist heat and take anti-inflammatory. Pt. presented to clinic 081810 at 3:30 pm with arm swollen to 90 x 75 mm, red, hot to touch, instructed to continue heat and anti-inflammatorys & to see private MD if worsens or no improvement. Also c/o mild headache and low grade temp.
Received injection 4-5-07 at 7:45 am states he didn't feel well that night 4-6-07 woke up with a headache, chills, cold sweat, face flushes. Vomited once, dizziness and abd pain LVQ.  Treatment-Phenergan 25 mg I PO q 4-6 hours prn. BP 124/69, P 80, 98 deg
Information has been received from a registered nurse concerning a female, with no pertinent medical history who on 04-NOV-2004 was vaccinated with Varivax. There was no concomitant therapy. Recently, the patient experienced chicken pox. The nurse had no further information on the development or number of pox/lesions present. The patient was vaccinated but not seen in the office for this case. It was noted that the patient sought medical attention. The patient was recovering. Additional information has been requested.
fever (24 hours), headache (48 hours), body soreness and nausea ongoing
Gave both vaccines flu and covid, one in each arm at about 8 pm.  10 minutes later, patient had trouble breathing.  Administered Epipen. Patient started to breathe better after epipen.  Fire department came and assessed her.   Went home on her own.
administered zoster vaccine live (ZOSTAVAX) at a dose of 0.5 (units not provided); This spontaneous report (split from legal case MARRS # 2008USA010988) was received from an other health professional via a Patient Vaccine Administration Record and from a physician via medical records, and refers to a 64-year-old male patient. No information about the patient's medical history, concurrent conditions or concomitant medications was provided. On 18-MAR-2013 (also reported as "3/18"), the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (also reported as "historical Zostervax"), dose: 0.5 (units not provided), lot # J000433 was found to be valid for zoster vaccine live (ZOSTAVAX), expiration date was not provided but upon internal validation established as 10-APR-2014, for prophylaxis (route of administration and anatomical location were not provided).  All available medical records will be provided upon request.  This is one two reports received from the same reporter.; Sender's Comments:  US-009507513-2008USA010988:
I missed my second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (I missed my second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (I missed my second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (I missed my second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication provided. No concomitant medication provided.
Headache, Fever, body aches, tiredness,  soreness at vaccination site (left upper arem).
Pt only reported sharp pain in left arm 30 min after injection. She took OTC pain tabs and used an ice pack. Pain started to go away 15 to 20 min. later.
Information has been received from a nurse referring to a patient of unknown age and gender. Information about concurrent condition, concomitant medication and medical history was not provided. On 11-AUG-2015, 20-OCT-2015, 16-FEB-2016 and 27-OCT-2016, the patient was inadvertently vaccinated with 4 doses of GARDASIL 9 (dose and route unknown for all doses) (lot# for first dose: K011562 which is invalid; lot# for second dose: L013429; lot# for third dose: L0183511 which is invalid; lot# for the fourth dose: M018810; expiration date for all doses were unknown) (Extra dose administered). No adverse effect reported. Additional information has been requested.
This spontaneous report was received from a physician through email via healthcare worker refers to a patient of unknown demography. On an unknown date the patient was vaccinated with PNEUMOVAX 23 lot # J009833 (Expiry: 25-JAN-2015) (dose, route and frequency was not reported). On an unknown date the patient experienced significant pain, redness and swelling at the injection site. The outcome of the event significant pain, redness and swelling at the injection site was unknown. The reporter did not provide the causality between the event of significant pain, redness and swelling at the injection site and the suspect drug. The case is linked to the case 1402USA006209, 1402USA007454 and 1402USA007455 (same reporter link). Additional information has been requested.
Patient's mom confirmed patient's birthday as 2001 when creating PHARMACY profile and also at the time of vaccine administration for 1st dose of Moderna on 04/29/2021. Patient received the first Moderna dose per protocol (18 years and above) and returned for 2nd dose on 05/27/2021. At that time, patient's mom reported his birthday as 2003 and so he can not qualify for 2nd dose Moderna because of the age limit. Pharmacist called (Clinical pharmacist) and per recommendation, we called patient's pediatrician (doctor) to get a RX for 2nd dose and doctor denied to writer a RX. Patient's mom decided to wait until he turns 18 in September 2021 for 2nd dose or until Moderna approves for the young age whichever is earlier.   Patient had no side effects of any kind per Mom and Patient verified after the first dose. They were here for 2nd dose and was unable to get it because of the age restrictions/limitation.
No adverse event; accidentally gave PNEUMOVAX 23 to a 6 month old instead of the PREVNAR 13; This spontaneous report as received from a physician refers to a 6-month-old female patient.  On 15-APR-2021, the physician accidentally gave pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23) (dose, LOT#, expiration date, route of administration and injection site were not provided) for prophylaxis to the patient instead of pneumococcal 13v conj vaccine (CRM197) (PREVNAR 13). No adverse events were reported.
4 hours after vaccines, Pt developed high fever up to 104 degrees, the following day some angioedema admitted to Hospital for consult-management at office. Then re-admitted with possible seizure.
Bruising at injection site.  3 inches below the Injection site was a red, swollen and hot to touch oval area 3 inches long and 2 inches wide
pain in her neck and ears at times; pain in her neck and ears at times; a clicking in her head; This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (pain in her neck and ears at times), NECK PAIN (pain in her neck and ears at times) and TINNITUS (a clicking in her head) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetic.   On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EAR PAIN (pain in her neck and ears at times), NECK PAIN (pain in her neck and ears at times) and TINNITUS (a clicking in her head). At the time of the report, EAR PAIN (pain in her neck and ears at times), NECK PAIN (pain in her neck and ears at times) and TINNITUS (a clicking in her head) had not resolved.            Concomitant product use was not provided by the reporter.   Treatment information was not provided.